These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4002734)

  • 1. Metabolism of phenylbutazone in rats.
    Alexander DM; Mathew GE; Wilson BJ
    Xenobiotica; 1985 Feb; 15(2):123-8. PubMed ID: 4002734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of phenylbutazone in man.
    Dieterle W; Faigle JW; Früh F; Mory H; Theoblad W; Alt KO; Richter WJ
    Arzneimittelforschung; 1976 Apr; 26(4):572-7. PubMed ID: 782467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the absorption, excretion, and metabolism of suxibuzone and phenylbutazone in humans.
    Yasuda Y; Shindo T; Mitani N; Ishida N; Oono F; Kageyama T
    J Pharm Sci; 1982 May; 71(5):565-72. PubMed ID: 7097505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of dietary portein on the disposition and metabolism of phenylbutazone in rats.
    Varma DR
    Can J Physiol Pharmacol; 1980 Mar; 58(3):231-6. PubMed ID: 7378926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolism of phenylbutazone in the rat.
    Bakke OM; Draffan GH; Davies DS
    Xenobiotica; 1974 Apr; 4(4):237-54. PubMed ID: 4603132
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of phenylbutazone and oxyphenbutazone on basic drug detection in high performance thin layer chromatographic systems.
    Woods WE; Chay S; Houston T; Blake JW; Tobin T
    J Vet Pharmacol Ther; 1985 Jun; 8(2):181-9. PubMed ID: 2862290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition and oxidative metabolism of phenylbutazone in man.
    Aarbakke J; Bakke OM; Milde EJ; Davies DS
    Eur J Clin Pharmacol; 1977; 11(5):359-66. PubMed ID: 880975
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolism, excretion, pharmacokinetics and tissue residues of phenylbutazone in the horse.
    Lees P; Taylor JB; Maitho TE; Millar JD; Higgins AJ
    Cornell Vet; 1987 Apr; 77(2):192-211. PubMed ID: 3568689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of labetalol by animals and man.
    Martin LE; Hopkins R; Bland R
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacokinetics of phenylbutazone.
    Aarbakke J
    Clin Pharmacokinet; 1978; 3(5):369-80. PubMed ID: 359213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenylbutazone and its metabolites in plasma and urine of thoroughbred horses: population distributions and effects of urinary pH.
    Houston T; Chay S; Woods WE; Combs G; Kamerling S; Blake JW; Edmundson AG; Vessiney R; Tobin T
    J Vet Pharmacol Ther; 1985 Jun; 8(2):136-49. PubMed ID: 4020945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of flumecinol in humans.
    Klebovich I; Vereczkey L; Tóth E; Tamás J; Mák M; Jalsovszky G; Holly S
    Xenobiotica; 1987 Oct; 17(10):1247-58. PubMed ID: 3424871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous determination of phenylbutazone and its metabolites in plasma and urine by high-performance liquid chromatography.
    Marunaka T; Shibata T; Minami Y; Umeno Y
    J Chromatogr; 1980 Sep; 183(3):331-8. PubMed ID: 7419650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of phenylbutazone and oxyphenbutazone in plasma and urine samples of horses by high-performance liquid chromatography and gas chromatography-mass spectrometry.
    Neto LM; Andraus MH; Salvadori MC
    J Chromatogr B Biomed Appl; 1996 Apr; 678(2):211-8. PubMed ID: 8738024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug interactions in the horse: effects of chloramphenicol, quinidine, and oxyphenbutazone on phenylbutazone metabolism.
    Tobin T; Blake JW; Valentine R
    Am J Vet Res; 1977 Jan; 38(1):123-7. PubMed ID: 835859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the chromatographic fractionation of metabolites of benzo[a]pyrene in faeces and urine from germfree and conventional rats.
    Egestad B; Pettersson P; Sjövall J; Rafter J; Hyvönen K; Gustafsson JA
    Biomed Chromatogr; 1987; 2(3):120-34. PubMed ID: 3507218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of 2-amino-3-methylimidazo[4,5-f]quinoline in the male rat.
    Inamasu T; Luks H; Vavrek MT; Weisburger JH
    Food Chem Toxicol; 1989 Jun; 27(6):369-76. PubMed ID: 2792966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue disposition and excretion of gold and 14C in rats treated with sodium aurothio[1,4-14C]malate or thio [1,4-14C] malic acid.
    Taylor A; King LJ; Marks V
    Xenobiotica; 1985 Mar; 15(3):221-6. PubMed ID: 3927598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolites of 2-(3-trifluoromethylphenyl)tetrahydro-1,4-oxazine (CERM) 1841) in rats and dogs.
    Kucharczyk N; Yang JT; Valia KH; Stiefel FJ; Sofia RD
    Xenobiotica; 1979 Nov; 9(11):703-11. PubMed ID: 532219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of 2- and 3-tert-butyl-4-hydroxyanisole in the rat (III): Metabolites in the urine and feces.
    Hirose M; Hagiwara A; Inoue K; Ito N; Kaneko H; Saito K; Matsunaga H; Isobe N; Yoshitake A; Miyamoto J
    Toxicology; 1988 Dec; 53(1):33-43. PubMed ID: 3201475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.